Literature DB >> 9435036

Purpura fulminans in pneumococcal sepsis: case report and review.

C T Carpenter1, A B Kaiser.   

Abstract

Purpura fulminans is classically defined by ecchymotic skin lesions, fever, and hypotension. The majority of cases occur in association with bacterial sepsis, and disseminated intravascular coagulation (DIC) is usually present. Prompted by our experience with a patient with pneumococcal sepsis and purpura fulminans in whom hypotension was never observed, we evaluated the important parameters of sepsis in reports of this syndrome. 42 additional cases of pneumococcal bacteremia and purpura fulminans were identified. Hypotension was present in only 51%. Although DIC was present in 85% of patients, hypofibrinogenemia was documented in only 26%. By contrast, both hypotension and hypofibrinogenemia are present in the vast majority of patients described with purpura fulminans in association with meningococcal sepsis. These data confirm that hypotension is not a necessary feature of the syndrome of purpura fulminans associated with pneumococcal sepsis and suggest further that qualitative or quantitative differences exist in the DIC cascade of pneumococcal vs meningococcal sepsis.

Entities:  

Mesh:

Year:  1997        PMID: 9435036     DOI: 10.3109/00365549709011858

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  3 in total

1.  Invasive Pneumococcal Disease: Still Lots to Learn and a Need for Standardized Data Collection Instruments.

Authors:  T J Marrie; G J Tyrrell; Sumit R Majumdar; Dean T Eurich
Journal:  Can Respir J       Date:  2017-03-23       Impact factor: 2.409

2.  Purpura Fulminans: a Rare but Fierce Presentation of Pneumococcal Sepsis.

Authors:  Adeel Nasrullah; Anam Javed; Usman Tariq; Meilin Young; Zunera Moeen; Marvin Balaan
Journal:  Eur J Case Rep Intern Med       Date:  2019-12-30

3.  Asphyxia by Drowning Induces Massive Bleeding Due To Hyperfibrinolytic Disseminated Intravascular Coagulation.

Authors:  Michael Schwameis; Andreas Schober; Christian Schörgenhofer; Wolfgang Reinhard Sperr; Herbert Schöchl; Karin Janata-Schwatczek; Erol Istepan Kürkciyan; Fritz Sterz; Bernd Jilma
Journal:  Crit Care Med       Date:  2015-11       Impact factor: 7.598

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.